Endo Pharmaceuticals (NASDAQ: ENDP) is going to be giving a presentation at the Bank of America Merrill Lynch 2010 Healthcare Conference. The company is scheduled to deliver their presentation at 11:20am (EDT) on May 12, 2010.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
The company’s President and CEO, David Holveck, will present an overview on the company’s products and development programs. A webcast of the presentation will be made available through the Investor s section of the Endo website.
Endo Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used to treat and manage pain, prostate cancer, bladder cancer and the early onset of puberty in children, or central precocious puberty (CPP).
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
